ABSTRACT
BACKGROUND: This research intended to predict the active ingredients and key target genes of Indigo Naturalis in treating human chronic myeloid leukemia (CML) using network pharmacology and conduct the invitro verification. METHODS: The active components of Indigo Naturalis and the corresponding targets and leukemia-associated genes were gathered through public databases. The core targets and pathways of Indigo Naturalis were predicted through protein-protein interaction (PPI) network, gene ontology (GO) function, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Next, after intersecting with leukemia-related genes, the direct core target gene of Indigo Naturalis active components was identified. Subsequently, HL-60 cells were stimulated with indirubin (IND) and then examined for cell proliferation using CCK-8 assay and cell cycle, cell apoptosis, and mitochondrial membrane potential using flow cytometry. The content of apoptosis-associated proteins (Cleaved Caspase 9, Cleaved Caspase 7, Cleaved Caspase 3, and Cleaved parp) were detected using Western blot, HSP90AA1 protein, and PI3K/Akt signaling (PI3K, p-PI3K, Akt, and p-Akt) within HL-60 cells. RESULTS: A total of 9 active components of Indigo Naturalis were screened. The top 10 core target genes (TNF, PTGS2, RELA, MAPK14, IFNG, PPARG, NOS2, IKBKB, HSP90AA1, and NOS3) of Indigo Naturalis active components within the PPI network were identified. According to the KEGG enrichment analysis, these targets were associated with leukemia-related pathways (such as acute myeloid leukemia and CML). After intersecting with leukemia-related genes, it was found that IND participated in the most pairs of target information and was at the core of the target network; HSP90AA1 was the direct core gene of IND. Furthermore, the in-vitro cell experiments verified that IND could inhibit the proliferation, elicit G2/M-phase cell cycle arrest, enhance the apoptosis of HL-60 cells, reduce mitochondrial membrane potential, and promote apoptosis-related protein levels. Under IND treatment, HSP90AA1 overexpression notably promoted cell proliferation and inhibited apoptosis. Additionally, IND exerted tumor suppressor effects on leukemia cells by inhibiting HSP90AA1 expression. CONCLUSION: IND, an active component of Indigo Naturalis, could inhibit CML progression, which may be achieved via inhibiting HSP90AA1 and PI3K/Akt signaling expression levels.
Subject(s)
Antineoplastic Agents , Apoptosis , Cell Proliferation , HSP90 Heat-Shock Proteins , Indoles , Phosphatidylinositol 3-Kinases , Proto-Oncogene Proteins c-akt , Humans , Cell Proliferation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Apoptosis/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Indoles/pharmacology , Indoles/chemistry , HSP90 Heat-Shock Proteins/antagonists & inhibitors , HSP90 Heat-Shock Proteins/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/chemical synthesis , Drug Screening Assays, Antitumor , HL-60 Cells , Molecular Structure , Dose-Response Relationship, Drug , Structure-Activity Relationship , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism , Leukemia/drug therapy , Leukemia/pathology , Leukemia/metabolism , Signal Transduction/drug effectsABSTRACT
Lentic systems (lakes and reservoirs) are emission hotpots of nitrous oxide (N2O), a potent greenhouse gas; however, this has not been well quantified yet. Here we examine how multiple environmental forcings have affected N2O emissions from global lentic systems since the pre-industrial period. Our results show that global lentic systems emitted 64.6 ± 12.1 Gg N2O-N yr-1 in the 2010s, increased by 126% since the 1850s. The significance of small lentic systems on mitigating N2O emissions is highlighted due to their substantial emission rates and response to terrestrial environmental changes. Incorporated with riverine emissions, this study indicates that N2O emissions from global inland waters in the 2010s was 319.6 ± 58.2 Gg N yr-1. This suggests a global emission factor of 0.051% for inland water N2O emissions relative to agricultural nitrogen applications and provides the country-level emission factors (ranging from 0 to 0.341%) for improving the methodology for national greenhouse gas emission inventories.
ABSTRACT
Dihydromyricetin (DHM) is a bioactive flavonoid extracted from Hovenia dulcis, which has various activities. In the present study, the molecular mechanism of dihydromyricetin (DHM) in relieving liver cirrhosis was investigated through network pharmacology and experimental verification. The cell model was induced by TGF-ß1 activating the human hepatic stellate cell line (HSC; LX-2). The protein levels of α-SMA, collagen I, and collagen III and pathway-related proteins within LX-2 cells were detected using Western blot. EdU staining was conducted to detect cell proliferation. Immunofluorescence staining was performed to detect the expression levels of α-SMA and collagen I. Next, the drug targets of DHM were screened from the PubChem database. The differentially expressed genes in the liver cirrhosis dataset GSE14323 were identified. The expression of the identified drug targets in LX-2 cells was verified using qRT-PCR. The results showed that TGF-ß1 treatment notably increased LX-2 cell viability, promoted cell proliferation, and elevated α-SMA, collagen I, and collagen III protein contents. DHM treatment could partially eliminate TGF-ß1 effects, as evidenced by the inhibited cell viability and proliferation and reduced α-SMA, collagen I, and collagen III contents. After network pharmacology analysis, nine differentially expressed target genes (MMP2, PDGFRB, PARP1, BCL2L2, ABCB1, TYR, CYP2E1, SQSTM1, and IL6) in liver cirrhosis were identified. According to qRT-PCR verification, DHM could inhibit the expression of MMP2, PDGFRB, PARP1, CYP2E1, SQSTM1, and IL6, and enhance ABCB1 expression levels within LX-2 cells. Moreover, DHM inhibited mTOR and MAPK signaling pathways in TGF-ß1-induced HSCs. In conclusion, DHM could inhibit HSC activation, which may be achieved via acting on MMP2, PDGFRB, PARP1, CYP2E1, SQSTM1, IL6, and ABCB1 genes and their downstream signaling pathways, including mTOR and MAPK signaling pathway.
Subject(s)
Flavonols , Matrix Metalloproteinase 2 , Transforming Growth Factor beta1 , Humans , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/pharmacology , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/metabolism , Cytochrome P-450 CYP2E1/metabolism , Interleukin-6/metabolism , Network Pharmacology , Receptor, Platelet-Derived Growth Factor beta/metabolism , Receptor, Platelet-Derived Growth Factor beta/therapeutic use , Sequestosome-1 Protein/metabolism , Liver Cirrhosis/drug therapy , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type I/therapeutic use , TOR Serine-Threonine Kinases/metabolismABSTRACT
Human-induced nitrogen-phosphorus (N, P) imbalance in terrestrial ecosystems can lead to disproportionate N and P loading to aquatic ecosystems, subsequently shifting the elemental ratio in estuaries and coastal oceans and impacting both the structure and functioning of aquatic ecosystems. The N:P ratio of nutrient loading to the Gulf of Mexico from the Mississippi River Basin increased before the late 1980s driven by the enhanced usage of N fertilizer over P fertilizer, whereafter the N:P loading ratio started to decrease although the N:P ratio of fertilizer application did not exhibit a similar trend. Here, we hypothesize that different release rates of soil legacy nutrients might contribute to the decreasing N:P loading ratio. Our study used a data-model integration framework to evaluate N and P dynamics and the potential for long-term accumulation or release of internal soil nutrient legacy stores to alter the ratio of N and P transported down the rivers. We show that the longer residence time of P in terrestrial ecosystems results in a much slower release of P to coastal oceans than N. If contemporary nutrient sources were reduced or suspended, P loading sustained by soil legacy P would decrease much slower than that of N, causing a decrease in the N and P loading ratio. The longer residence time of P in terrestrial ecosystems and the increasingly important role of soil legacy nutrients as a loading source may explain the decreasing N:P loading ratio in the Mississippi River Basin. Our study underscores a promising prospect for N loading control and the urgency to integrate soil P legacy into sustainable nutrient management strategies for aquatic ecosystem health and water security.
Subject(s)
Ecosystem , Soil , Humans , Soil/chemistry , Rivers/chemistry , Fertilizers , Nutrients , Phosphorus , Nitrogen/analysisABSTRACT
The detection of carcinoembryonic antigen (CEA) has profound implications in cancer diagnostics and therapeutic monitoring. In this work, we developed a colorimetric immunoassay for the detection of CEA. This assay involves the utilization of zinc(II)-based coordination polymers (ZnCPs) as a host for integrating glucose oxidase (GOx) and anti-carcinoembryonic antigen antibody (anti-CEA), which results in the formation of a detection antibody (anti-CEA/GOx@ZnCPs). The adaptable inclusion properties of ZnCPs enable the preservation of the original catalytic behavior of GOx and antigen capture ability of anti-CEA. Consequently, the anti-CEA/GOx@ZnCPs can act as a detection antibody to facilitate the development of an immunoassay. The combination of anti-CEA/GOx@ZnCPs in the immunoassay triggers a cascade reaction involving GOx and MnO2 nanosheets, leading to the generation of an amplified colorimetric signal through self-supplying oxygen. This colorimetric immunoassay exhibits a linear response ranging from 2 to 180 ng mL-1 CEA and has a detection limit of 50 pg mL-1. The practicality of this colorimetric immunoassay in biological matrices was demonstrated by the successful determination of CEA in serum samples with good recovery and precision. We believe that this study will pave the way to rationally design multifunctional CP-based composites for a wide range of applications in bioanalysis.
Subject(s)
Carcinoembryonic Antigen , Glucose Oxidase , Carcinoembryonic Antigen/analysis , Colorimetry/methods , Manganese Compounds , Oxides , Immunoassay/methods , Antibodies, MonoclonalABSTRACT
Expression of Concern for 'Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery' by Jianxin Liu et al., Biomater. Sci., 2018, 6, 2838-2849, https://doi.org/10.1039/C8BM00726H.
ABSTRACT
Objectives: Liver fibrosis is a common liver disease caused by chronic liver damage. However, there are currently no approved drugs available to treat it. Therefore, the therapeutic effect of indirubin on liver fibrosis was evaluated. This study investigated the protective effect and related molecular mechanism of indirubin against CCl4-induced liver fibrosis in mice. Materials and Methods: We first detected the effect of indirubin on liver fibrosis in mice (n=8 per group, 32 mice total) by ELISA, HE, and Masson staining. Subsequently, the proliferation of activated HSCs was detected by MTT and EdU. Finally, the changes of related proteins and signaling pathways in mice treated with indirubin were investigated by qRT-PCR and Western blot. One-way ANOVA or two-tailed student's t-test was used for comparison between groups. Results: Firstly, we found that indirubin (25 mg/kg) therapy could attenuate liver injury and significantly down-regulate α-SMA (P=0.0038) and collagen 1 (P=0.0057) in the liver using CCl4-induced liver fibrosis in mice. Secondly, we showed that indirubin (25 µM) could significantly inhibit hepatic stellate cell (HSC) trans-differentiation into myofibroblasts and proliferation (P=0.0063) in HSC-T6 cells treated by TGF-ß. Finally, we showed that indirubin could greatly reduce the protein levels of p-Smad2/3, p38, p-ERK, and p-JNK in vivo and in vitro. Conclusion: Our results suggested that indirubin alleviated liver fibrosis and HSC activation mainly through TGF-ß-mediated signaling pathways in vivo and in vitro. In conclusion, our data showed that indirubin could be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis.
ABSTRACT
Rainfall kinetic energy (RKE) constitutes one of the most critical factors that drive rainfall erosivity on surface soil. Direct measurements of RKE are limited, relying instead on the empirical relations between kinetic energy and rainfall intensity (KE-I relation), which have not been well regionalized for data-scarce regions. Here, we present the first global rainfall microphysics-based RKE (RKEMPH) flux retrieved from radar reflectivity at different frequencies. The results suggest that RKEMPH flux outperforms the RKE estimates derived from a widely used empirical KE-I relation (RKEKE-I) validated using ground disdrometers. We found a potentially widespread underestimation of RKEKE-I, which is especially prominent in some low-income countries with ~20% underestimation of RKE and the resultant rainfall erosivity. Given the evidence that these countries are subject to greater rainfall-induced soil erosion, these underestimations would mislead conservation practices for sustainable development of terrestrial ecosystems.
ABSTRACT
The recent rise in atmospheric methane (CH4 ) concentrations accelerates climate change and offsets mitigation efforts. Although wetlands are the largest natural CH4 source, estimates of global wetland CH4 emissions vary widely among approaches taken by bottom-up (BU) process-based biogeochemical models and top-down (TD) atmospheric inversion methods. Here, we integrate in situ measurements, multi-model ensembles, and a machine learning upscaling product into the International Land Model Benchmarking system to examine the relationship between wetland CH4 emission estimates and model performance. We find that using better-performing models identified by observational constraints reduces the spread of wetland CH4 emission estimates by 62% and 39% for BU- and TD-based approaches, respectively. However, global BU and TD CH4 emission estimate discrepancies increased by about 15% (from 31 to 36 TgCH4 year-1 ) when the top 20% models were used, although we consider this result moderately uncertain given the unevenly distributed global observations. Our analyses demonstrate that model performance ranking is subject to benchmark selection due to large inter-site variability, highlighting the importance of expanding coverage of benchmark sites to diverse environmental conditions. We encourage future development of wetland CH4 models to move beyond static benchmarking and focus on evaluating site-specific and ecosystem-specific variabilities inferred from observations.
Subject(s)
Ecosystem , Wetlands , Methane/analysis , Climate Change , Forecasting , Carbon DioxideABSTRACT
BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an intestinally produced hormone released by the L-cells to stimulate glucose-dependent insulin release. Vine tea, a traditional Chinese medicine made from the delicate stem and leaves of Ampelopsis grossedentata, has been reported to exert antidiabetic effects; however, the role and mechanism of dihydromyricetin, the main active ingredient of vine tea, remain unclear. METHODS AND RESULTS: MTT assay was applied to detect cell viability. GLP-1 levels in the culture medium using a mouse GLP-1 ELISA kit. The level of GLP-1 in cells was examined using IF staining. NBDG assay was performed to evaluate the glucose uptake by STC-1 cells. The in vivo roles of dihydromyricetin in the diabetes mellitus mouse model were investigated. In this study, 25 µM dihydromyricetin, was found to cause no significant suppression of STC-1 cell viability. Dihydromyricetin markedly elevated GLP-1 secretion and glucose uptake by STC-1 cells. Although metformin increased GLP-1 release and glucose uptake by STC-1 cells more, dihydromyricetin further enhanced the effects of metformin. Moreover, dihydromyricetin or metformin alone significantly promoted the phosphorylation of AMPK, increased GLUT4 levels, inhibited ERK1/2 and IRS-1 phosphorylation, and decreased NF-κB levels, and dihydromyricetin also enhanced the effects of metformin on these factors. The in vivo results further confirmed the antidiabetic function of dihydromyricetin. CONCLUSION: Dihydromyricetin promotes GLP-1 release and glucose uptake by STC-1 cells and enhances the effects of metformin upon STC-1 cells and diabetic mice, which might ameliorate diabetes through improving L cell functions. The Erk1/2 and AMPK signaling pathways might be involved.
Subject(s)
Diabetes Mellitus, Experimental , Metformin , Animals , Metformin/pharmacology , Glucagon-Like Peptide 1/metabolism , AMP-Activated Protein Kinases , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Glucose , Tea , Insulin/metabolismABSTRACT
Inland waters (rivers, lakes, and reservoirs) have been recognized as hotspots of methane (CH4) emissions. However, the magnitude and spatiotemporal pattern of CH4 emissions and their underlying mechanisms remain largely unknown due to a lack of process-based quantification of CH4 production, consumption, and evasion within the aquatic ecosystem. Here we developed a process-based aquatic CH4 module within the framework of the Dynamic Land Ecosystem Model (DLEM) to explicitly simulate inland water carbon fluxes and the associated CH4 processes. We further applied this model to assess the inland-water CH4 emissions across the conterminous United States (CONUS) as affected by the climate variability, land use, fertilizer nitrogen (N) application, atmospheric N deposition, and rising atmospheric CO2 concentration during 1860-2019. The inland water CH4 emissions across the CONUS had doubled from the 1860s (1.65±0.18 Tg CH4-Câyr-1) to the 2010s (3.73±0.36 Tg CH4-Câyr-1). In the 2000s, inland water accounts for 8% of the regional CH4 budget that offsets 11â¼14% of the terrestrial C uptake across the CONUS. Our study showed that the small headwater streams (1st -3rd order) account for 49% of the diffusive CH4, and reservoirs constitute 50% of the ebullitive CH4 emissions during the 2010s. Climate change and variability played a dominant role in the increased CH4 emissions from rivers and lakes. This study implies that effective mitigation strategies to reduce CH4 emissions should pay much attention to global climate change and headwater stream management.
Subject(s)
Carbon Dioxide , Ecosystem , Carbon/analysis , Fertilizers , Methane , Nitrogen , United States , WaterABSTRACT
Panzhihua City, a typical eco-fragile region for agro-sylvo-pastoral industry in China, is located in the dry-hot valley of the Jinsha River, characterized by its big landform undulation, great elevation difference, uneven hydrothermal conditions, and complex geological structure. As a crucial ecological barrier in upper reaches of the Yangtze River, this area is abundant in water resources and mineral resources, such as vanadium and titanium. However, due to its over-development for nonnatural urban economy in the mining industry, agriculture, and animal husbandry, ecological problems are getting worse. Such problems as soil erosion and groundwater pollution have led obvious ecological degeneration in Panzhihua city. Therefore, for protecting the eco-environment and planning construction, it is significant to scientifically recognize that how eco-environment changes based on spatial-temporal, and how the driving mechanism affects Panzhihua city. Nowadays, there are some theories and methods that study eco-environmental protection and city construction in Panzhihua, but they are not comprehensive enough to study its spatial-temporal evolution and driving-force system. This study takes Panzhihua City as the research area of which evaluation factors, for example, topography, soil, vegetation, and meteorological factors, are chosen to construct an evaluation system suitable for the ecological environment vulnerability of Panzhihua City. These factors are selected in three aspects, which are ecological sensitivity, ecological recovery, and ecological pressure from 2005 to 2015 in this area. Then, spatial principal component analysis method, CA-Markov model, and dynamic degree model are applied to analyze the spatial-temporal evolution for ecological vulnerability based on three periods from 2005 to 2015 in Panzhihua City. Besides, GeoDetector is used to quantitatively analyze how spatial-temporal disparities change and what drives them to change. The results show that (1) during these 10 years, the overall ecological fragility of Panzhihua City is steadily increasing from northwest to southeast. The overall ecological quality is moderate, and regional differences are obvious. Places of moderate vulnerability or above are distributed in central and eastern regions of frequent human activities; places of mild vulnerability or below are distributed in the regions of Yanbian County and Miyi County. (2) The comparison of the changing rates based on vulnerability levels is severe > potential > moderate > mild > slight. The overall vulnerability changes within a small trend, showing a balanced two-way transition state between adjacent vulnerability levels. The comprehensive index for overall ecological vulnerability decreases period by period. (3) The interactions between each two factors toward spatial differentiation and explanatory power by ecological vulnerability show a two-factor-enhanced relation, indicating that multiple factors form the ecological vulnerability of Panzhihua City.
Subject(s)
Ecology , Environmental Monitoring , China , Cities , Conservation of Natural Resources , Ecosystem , HumansABSTRACT
As a non-invasive therapeutic, radiotherapy (RT) has been extensively used for solid tumor treatment. However, intratumoral hypoxia leads to severe RT resistance or failure. Moreover, damage from RT to normal tissues limits the application of high doses of radiation to eliminate cancer cells. Therefore, simultaneously improving the curative efficacy while minimizing the side effects of RT is in pressing need. Hence, the purpose of this study is to use oxygen-based microbubbles (O2 @MBs) combined with ultrasound (US) targeting microbubble destruction (UTMD) technology to overcome hypoxia prior to RT, evaluate the effects of O2 @MBs on contrast-enhanced ultrasound (CEUS) imaging enhancement, investigate the optimum delivery route of O2 @MBs, and evaluate the therapeutic efficacy. In this study, O2 @MBs were injected intravenously or locally and the distribution of O2 @MBs in tumors or regions surrounding the tumors are compared by US imaging. The hypoxic status of tumors and their sensitivity to RT were investigated. Our findings suggest that O2 @MBs combined with UTMD can significantly enhance the effects of RT. In addition, the in vivo biosafety assay demonstrates good biocompatibility, indicating great potential for clinical translation.
Subject(s)
Microbubbles , Neoplasms , Humans , Neoplasms/diagnostic imaging , Neoplasms/radiotherapy , Oxygen , UltrasonographyABSTRACT
Theranostics is a new trend in the tumor research field, which involves the integration of diagnostic and therapeutic functions using imageable nanoparticles coupled with therapeutic drugs. Imaging-guided targeted delivery of therapeutics and diagnostics using nanocarriers hold great promise to minimize the side effects of conventional chemotherapy. Ultrasound microbubbles have been employed as theranostic agents over the last decade, which provide both real-time dynamic imaging for diagnosis and precise control for targeted tumor therapy. However, the intrinsic defects of microbubbles such as poor tissue penetration, short circulation time and instability hinder microbubble-based theranostic applications. In recent years, liquid-to-gas transitional perfluorocarbon nanoparticles have been developed as promising diagnostic and therapeutic nanoagents to solve the abovementioned problems. In this study, phase-changeable, folate-targeted perfluoropentane nanodroplets loaded with 10-hydroxycamptothecin (HCPT) and superparamagnetic Fe3O4 (denoted as FA-HCPT-Fe3O4-PFP NDs) are prepared and investigated for multimodal tumor imaging and targeted therapy. After intravenous administration into nude mice bearing SKOV3 ovarian cancer, FA-HCPT-Fe3O4-PFP NDs exhibit the ability to enhance MR and PA imaging. Furthermore, after the phase transition activated by low-intensity focused ultrasound (LIFU) sonication, FA-HCPT-Fe3O4-PFP NDs remarkably enhance US imaging at the tumor location. Meanwhile, the HCPT released from FA-HCPT-Fe3O4-PFP NDs during the liquid-to-gas transition provides a therapeutic effect on tumor cells with relatively low side effects to normal tissue. Therefore, the combination of LIFU and FA-HCPT-Fe3O4-PFPNDs presents an ideal modality for tumor-targeted theranostics.
Subject(s)
Drug Delivery Systems/methods , Molecular Imaging/methods , Nanostructures/chemistry , Theranostic Nanomedicine/methods , Ultrasonic Waves , Animals , Camptothecin/analogs & derivatives , Camptothecin/chemistry , Cell Line, Tumor , Cell Transformation, Neoplastic , Fluorocarbons/chemistry , Folic Acid/chemistry , Humans , Magnetite Nanoparticles/chemistry , Mice , Mice, Nude , Tissue DistributionABSTRACT
Background: As one of the most effective triggers with high tissue-penetrating capability and non-invasive feature, ultrasound shows great potential for controlling the drug release and enhancing the chemotherapeutic efficacy. In this study, we report, for the first time, construction of a phase-changeable drug-delivery nanosystem with programmable low-intensity focused ultrasound (LIFU) that could trigger drug-release and significantly enhance anticancer drug delivery. Methods: Liquid-gas phase-changeable perfluorocarbon (perfluoropentane) and an anticancer drug (doxorubicin) were simultaneously encapsulated in two kinds of nanodroplets. By triggering LIFU, the nanodroplets could be converted into microbubbles locally in tumor tissues for acoustic imaging and the loaded anticancer drug (doxorubicin) was released after the microbubble collapse. Based on the acoustic property of shell materials, such as shell stiffness, two types of nanodroplets (lipid-based nanodroplets and PLGA-based nanodroplets) were activated by different acoustic pressure levels. Ultrasound irradiation duration and power of LIFU were tested and selected to monitor and control the drug release from nanodroplets. Various ultrasound energies were introduced to induce the phase transition and microbubble collapse of nanodroplets in vitro (3 W/3 min for lipid nanodroplets; 8 W/3 min for PLGA nanodroplets). Results: We detected three steps in the drug-releasing profiles exhibiting the programmable patterns. Importantly, the intratumoral accumulation and distribution of the drug with LIFU exposure were significantly enhanced, and tumor proliferation was substantially inhibited. Co-delivery of two drug-loaded nanodroplets could overcome the physical barriers of tumor tissues during chemotherapy. Conclusion: Our study provides a new strategy for the efficient ultrasound-triggered chemotherapy by nanocarriers with programmable LIFU capable of achieving the on-demand drug release.
Subject(s)
Drug Liberation , Nanoparticles/chemistry , Phase Transition , Ultrasonics , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Emulsions/chemistry , Female , Humans , Mice, Inbred BALB C , Mice, Nude , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Tissue Distribution , Treatment Outcome , Tumor BurdenABSTRACT
Background: The construction of theranostic nanosystems with concurrently high biosafety and therapeutic performance is a challenge but has great significance for the clinical translation of nanomedicine for combating cancer. Methods: Bio-inspired melanin-based nanoliposomes (Lip-Mel) as theranostic agents were constructed for simultaneous photoacoustic (PA) imaging- and T1-weighted magnetic resonance (MR) imaging-guided photothermal ablation of tumors, which was demonstrated both in vitro and in vivo. The high biosafety of Lip-Mel was also systematically evaluated. Results: The achieved Lip-Mel nanoliposomes demonstrated their imaging capability for both PA and T1-weighted MR imaging (r1 = 0.25 mM-1·s-1) both in vitro and in vivo, providing the potential for therapeutic guidance and monitoring. Importantly, the desirable photothermal-conversion efficiency of the as-prepared Lip-Mel achieved complete eradication of tumors in breast cancer-bearing mice, exhibiting remarkable photothermal-based therapeutic performance. In particular, the efficient encapsulation of melanin into the PEGylated liposome mitigated the potential toxicity of melanin and improved the photothermal performance of the loaded melanin. Systematic in vivo biosafety evaluations demonstrated the high biocompatibility of Lip-Mel at a high dose of 100 mg/kg. Conclusion: In this work, we reported a bioinspired strategy where melanin, a natural product in the human body, is encapsulated into PEGylated nanoliposomes for efficient theranostics with high biocompatibility. This work provides a new strategy for creating desirable theranostic agents with concurrent high biocompatibility and satisfactory theranostic performance through the use of materials that totally originate from biosystems.
Subject(s)
Breast Neoplasms/therapy , Combined Modality Therapy/methods , Liposomes/therapeutic use , Melanins/pharmacology , Nanoparticles/therapeutic use , Photosensitizing Agents/pharmacology , Ablation Techniques , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Cell Line, Tumor , Drug Compounding/methods , Female , Humans , Liposomes/chemistry , Magnetic Resonance Imaging/methods , Melanins/chemistry , Mice , Mice, Nude , Nanoparticles/chemistry , Photoacoustic Techniques , Photochemotherapy/methods , Photosensitizing Agents/chemistry , Polyethylene Glycols/chemistry , Theranostic Nanomedicine/methods , Xenograft Model Antitumor AssaysABSTRACT
OBJECTIVES: To determine whether combining microbubbles (MBs) with diagnostic ultrasound (US) at a high mechanical index (MI) could enhance the microwave (MW) ablation of tumours. MATERIALS AND METHODS: Five therapeutic MW adjuvant protocols were studied: MW, MW + US, MW + US + MB, MW + US + NS (saline) and MW + MB. In 30 normal rabbit livers, the synergistic effects were evaluated via temperature, necrosis volume and histology. In 90 VX2 rabbit hepatic tumours, residual cells in the peripheral ablated tumours were examined via immunohistochemical assay and tumour growth. Additional 40 VX2 hepatic tumours were evaluated for ablation safety via blood assay and weight and for survival to 105 days. Results were compared using analysis of variance. RESULTS: Compared with the other protocols, the ablation volumes in normal rabbit livers were significantly larger using the MW + US + MB protocol (p < .001). The histological examination was consistent with more efficient ablation in that protocol. In detecting residual cells, the apoptotic index was higher, the proliferating index was lower (p < .05), tumour growth was significantly smaller (p < .001), and the rabbits of the MW + US + MB T-Group survived longer (p < .05) than those of the other groups. Additionally, no damage to the liver function or blood cells was found in any of the protocols after ablation (p < .05). CONCLUSIONS: MBs in combination with diagnostic US at a high MI showed potential synergy in the MW ablation of tumours in rabbits.
ABSTRACT
Microbubbles (MBs) are considered as an important enhancer for high intensity focused ultrasound (HIFU) treatment of benign or malignant tumors. Recently, different sizes of gas-filled bubbles have been investigated to improve the therapeutic efficiency of HIFU thermal ablation and reduce side effects associated with ultrasound power and irradiation time. However, nanobubbles (NBs) as an ultrasound contrast agent for synergistic therapy of HIFU thermal ablation remain controversial due to their small nano-size in diameter. In this study, phospholipid-shell and gas-core NBs with a narrow size range of 500-600 nm were developed. The synergistic effect of NBs for HIFU thermal ablation was carefully studied both in excised bovine livers and in breast tumor models of rabbits, and made a critical comparison with that of commercial SonoVue microbubbles (SonoVue MBs). In addition, the pathological changes of the targeted area in tumor tissue after HIFU ablation were further investigated. Phosphate buffer saline (PBS) was used as the control. Under the same HIFU parameters, the quantitative echo intensity of B-mode ultrasound image and the volume of coagulative necrosis in lipid NBs groups were significantly higher and larger than that in PBS groups, but could not be demonstrated a difference to that in SonoVue MBs groups both ex vivo and in vivo. These results showed that the synergistic effect of lipid NBs for HIFU thermal ablation were similar with that of SonoVue MBs, and further indicate that lipid NBs could potentially become an enhancer for HIFU thermal ablation of tumors.
ABSTRACT
High-intensity focused ultrasound (HIFU) is deemed to be a promising noninvasive therapeutic modality for cancers as well as non-neoplastic diseases. However, the accuracy of the technique in the diagnosis and treatment of tumors remains unsatisfactory. HIFU, when combined with multifunctional synergistic agents (SAs), has the potential to be of greater diagnostic and therapeutic efficacy. Here we describe a smart and multifunctional hollow mesoporous Prussian blue (HMPBs) theranostic nanoplatform, the hollow structure of which is capable of encapsulating doxorubicin (DOX) and perfluorohexane (HMPBs-DOX/PFH). In vitro and in vivo studies validated that HMPBs-DOX/PFH can be used as an amplifiable dual-mode imaging contrast agent, which can simultaneously enhance ultrasound (US) and photoacoustic (PA) imaging for guiding and monitoring tumor therapy. When exposed to HIFU, this versatile HMPBs-DOX/PFH agent could increase the cavitation effect and use lower HIFU intensity to achieve coagulative necrosis. Furthermore, it significantly accelerated the release of DOX thereby enhancing chemotherapeutic efficacy and avoiding systemic side effects of the drug. Such a novel theranostic nanoplatform is expected to integrate dual-mode guided imaging with greater therapeutic efficacy and fewer side effects and is very promising for the noninvasive synergistic tumor therapy.
Subject(s)
Antineoplastic Agents/therapeutic use , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/drug therapy , Combined Modality Therapy/methods , Drug Carriers/pharmacokinetics , High-Intensity Focused Ultrasound Ablation/methods , Theranostic Nanomedicine/methods , Animals , Cattle , Cell Line, Tumor , Disease Models, Animal , Doxorubicin , Female , Ferrocyanides/metabolism , Fluorocarbons , Humans , Liver/pathology , Nanoparticles , Optical Imaging , Photoacoustic Techniques , RabbitsABSTRACT
Photothermal therapy (PTT) utilizes photothermal conversion reagents to generate heat energy from absorbed light to effectively treat various malignant diseases. This approach has attracted broad and increasing interest in cancer treatment. Near-infrared (NIR)-induced PTT is particularly attractive because of its minimal absorbance by normal tissue and relatively deep tissue penetration. To improve the efficacy of PTT, we have developed nanocapsules encapsulating superparamagnetic iron oxide (Fe3O4) as synergistic agents for NIR-induced PTT. In this study, phase-shift and NIR photoabsorbing poly(lactic-co-glycolic acid) (PLGA) nanocapsules (perfluorohexane (PFH)@PLGA/Fe3O4) were fabricated for MRI/US dual-modal imaging-guided PTT. The multifunctional nanocapsules can be used not only to increase the local tumor temperature by absorbing the NIR energy but also as bimodal contrast agents for both MRI and US imaging. Such nanocapsules can be converted into microbubbles under NIR irradiation, which produces excellent contrast for US imaging and enhanced cancer ablation. We refer to the nanocapsule phase transition process induced by the infrared lamp as NIR radiation droplet vaporization (NIRDV).